C

Corbus Pharmaceuticals Holdings
D

CRBP

12.455
USD
-0.16
(-1.27%)
Market Closed
Volume
2,203
EPS
-5
Div Yield
-
P/E
-3
Market Cap
151,695,448
OverviewSignalsIdeasNews
Related Instruments
    A
    ACAD
    0.225
    (1.29%)
    17.625 USD
    A
    AKTX
    0.03000
    (2.22%)
    1.38000 USD
    C
    CARA
    0.08000
    (1.66%)
    4.90000 USD
    C
    CRSP
    -0.660
    (-1.57%)
    41.270 USD
    M
    MRNS
    0.00000
    (0.00%)
    0.53200 USD
    T
    TLRY
    -0.08000
    (-5.50%)
    1.37500 USD
    Z
    ZYNE
    0
    (0%)
    0.000000 USD
    More
News

Title: Corbus Pharmaceuticals Holdings

Sector: Healthcare
Industry: Biotechnology
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.